Sandeep B. Kedia

Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity

Thomas A. Brandt, Stéphane Caron, David B. Damon et al. · Tetrahedron · 2008 · 24 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Bioindustrial manufacturing readiness levels (BioMRLs) as a shared framework for measuring and communicating the maturity of bioproduct manufacturing processes

Michael J. Smanski, Aristos Aristidou, Ryan Carruth et al. · Journal of Industrial Microbiology & Biotechnology · 2022 · 24 citations · Full text

Engineering, Bioengineering, Manufacturing Engineering +13

Reaction Progress Analysis: Powerful Tool for Understanding Suzuki−Miyaura Reaction and Control of Polychlorobiphenyl Impurity

Sandeep B. Kedia, Mark B. Mitchell · Organic Process Research & Development · 2009 · 22 citations

Natural Sciences, Chemical Engineering, Chemistry +17

Biomanufacturing readiness levels [BRL]—A shared vocabulary for biopharmaceutical technology development and commercialization

Sandeep B. Kedia, Jeffrey C. Baker, Ruben G. Carbonell et al. · Biotechnology and Bioengineering · 2022 · 17 citations · Full text

Engineering, Bioengineering, Manufacturing Engineering +15

Expedited Development through Parallel Reaction Screening: Application to PTC-Mediated Knoevenagel Condensation

J. Corona, Roman Davis, Sandeep B. Kedia et al. · Organic Process Research & Development · 2010 · 14 citations

Pharmacy, Chemistry, Medicinal Chemistry +14